FWP

Filed pursuant to Rule 433

Dated November 16, 2022

Issuer Free Writing Prospectus supplementing the

Preliminary Prospectus Supplement

dated November 16, 2022 and the

Prospectus dated November 16, 2022

Registration No. 333-268404

Brookdale Senior Living Inc.

Offering of

2,500,000 7.00% Tangible Equity Units

(the “Units Offering”)

The information in this pricing term sheet relates only to the Units Offering and should be read together with (i) the preliminary prospectus supplement, dated November 16, 2022 (the “Preliminary Prospectus Supplement”), as filed with the Securities and Exchange Commission (the “SEC”) pursuant to Rule 424(b) under the Securities Act of 1933, as amended, and (ii) the related base prospectus dated November 16, 2022 included in the Registration Statement (File No. 333-268404), in each case, including the documents incorporated by reference therein. Terms used but not defined herein have the meanings assigned to such terms in the Preliminary Prospectus Supplement.


Issuer:		Brookdale Senior Living Inc., a Delaware corporation.

Ticker / Exchange for Common Stock:		BKD/New York Stock Exchange (“NYSE”)

Pricing Date:		November 16, 2022.

Settlement Date:		November 21, 2022.

Last Reported Sale Price of the Common Stock on the NYSE on the Pricing Date:		$3.29

Title of Securities:		7.00% Tangible Equity Units (the “Units”).

Number of Units Offered:		2,500,000 Units (or 2,875,000 Units if the underwriters exercise their over-allotment option to purchase additional Units in full).

Stated Amount:		Each Unit has a stated amount of $50.00.

Composition of Units:		Each Unit is comprised of two parts: • a prepaid stock purchase contract issued by Issuer (a “Purchase Contract”); and • a senior amortizing note issued by Issuer (an “Amortizing Note”), which has an initial principal amount of $8.8996 per Amortizing Note, bears interest at a rate of 10.25% per annum and has a final installment payment date of November 15, 2025.


Fair Market Value of the Units:		Issuer has determined that the fair market value of each Amortizing Note is $8.8996 and the fair market value of each Purchase Contract is $41.1004.

Reference Price:		$50.00 divided by the Maximum Settlement Rate (rounded to the nearest $0.0001), which is initially approximately equal to the last reported sale price of Issuer’s Common Stock on the NYSE on the Pricing Date.

Threshold Appreciation Price:		$50.00 divided by the Minimum Settlement Rate (rounded to the nearest $0.0001), which is initially approximately $3.87 and represents an approximately 17.50% appreciation over the Reference Price.

Minimum Settlement Rate:		12.9341 shares of Common Stock per Purchase Contract (subject to adjustment as described in the Preliminary Prospectus Supplement).

Maximum Settlement Rate:		15.1976 shares of Common Stock per Purchase Contract (subject to adjustment as described in the Preliminary Prospectus Supplement).

Settlement Rate:		The following table illustrates the settlement rate per Purchase Contract and the value of Common Stock issuable upon settlement on the Mandatory Settlement Date, or in respect of any early settlement of a Purchase Contract at the option of a holder as described under “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus Supplement (other than in connection with a fundamental change), determined using the “applicable market value” (as defined in the Preliminary Prospectus Supplement) shown, subject to adjustment as described in the Preliminary Prospectus Supplement:


Applicable Market Value of Common Stock	Settlement Rate	Value of Common Stock Delivered (Based on the Applicable Market Value Thereof)

Less than the Reference Price	The Maximum Settlement Rate	Less than $50.00

Greater than or equal to the Reference Price but less than or equal to the Threshold Appreciation Price	A number of shares of Common Stock equal to $50.00, divided by the applicable market value	$50.00

Greater than the Threshold Appreciation Price	The Minimum Settlement Rate	Greater than $50.00

Early Settlement at Holder’s Election:

Until 5:00 p.m., New York City time, on the second scheduled trading day immediately preceding November 15, 2025, a holder may settle any or all of its Purchase Contracts early only under the following circumstances:

•

on or after February 15, 2023, on the second trading day immediately following the last trading day of any 20 consecutive trading day period during which the closing price of Common Stock has been greater than or equal to 110% of the Threshold Appreciation Price then in effect on each trading day in such 20 consecutive trading day period;

•

on or after February 15, 2023, during the five business day period after any ten consecutive trading day period (the “measurement period”) in which (x) the “trading price” (as defined under “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus Supplement) per Unit for each trading day of the measurement period was less than 97% of the product of the closing price of Common Stock and the Maximum Settlement Rate on each such trading day and (y) the closing price of Common Stock on each trading day of the measurement period was less than 70% of the Reference Price; or

•

upon the occurrence of specified corporate events as described under “Description of the Purchase Contracts—Early Settlement—Early Settlement upon Specified Corporate Events” in the Preliminary Prospectus Supplement.

If a holder elects to settle any or all of its Purchase Contracts early in accordance with the foregoing conditions, Issuer will deliver a number of shares of Common Stock for each such Purchase Contract based on the applicable Settlement Rate, unless such holder elects to settle its Purchase Contracts early in connection with a fundamental change, in which case such holder will receive upon settlement of such Purchase Contracts a number of shares of Common stock based on the fundamental change early settlement rate.

Upon early settlement at the holder’s election of a Purchase Contract that is a component of a Unit, the corresponding Amortizing Note will remain outstanding and beneficially owned by or registered in the name of, as the case may be, the holder who elected to settle the related Purchase Contract early.

Early Settlement Upon a Fundamental Change:

The following table sets forth the “fundamental change early settlement rate” (as defined in the Preliminary Prospectus Supplement) per Purchase Contract for each stock price and effective date set forth below:


Stock Price
Effective Date	$1.50		$2.00		$2.50		$3.00		$3.29		$3.50		$3.87		$4.50		$5.00		$6.00		$8.00		$10.00		$20.00		$30.00
November 21, 2022		13.9308		13.5680		13.2984		13.1084		13.0266		12.9776		12.9090		12.8278		12.6680		12.6512		12.6648		12.6869		12.7305		12.7373
February 15, 2023		14.0349		13.6607		13.3741		13.1688		13.0795		13.0259		12.9506		12.8612		12.7016		12.6798		12.6893		12.7093		12.7480		12.7536
May 15, 2023		14.1442		13.7602		13.4557		13.2332		13.1356		13.0767		12.9939		12.8951		12.7358		12.7086		12.7138		12.7315		12.7652		12.7699
August 15, 2023		14.2548		13.8641		13.5413		13.3002		13.1934		13.1287		13.0374		12.9284		12.7693		12.7364		12.7374		12.7529		12.7817		12.7856
November 15, 2023		14.3742		13.9805		13.6381		13.3753		13.2575		13.1858		13.0844		12.9632		12.8042		12.7650		12.7614		12.7746		12.7985		12.8018
February 15, 2024		14.4981		14.1077		13.7454		13.4578		13.3269		13.2470		13.1336		12.9981		12.8390		12.7929		12.7850		12.7958		12.8151		12.8179
May 15, 2024		14.6249		14.2474		13.8660		13.5498		13.4032		13.3132		13.1851		13.0323		12.8730		12.8198		12.8078		12.8164		12.8314		12.8340
August 15, 2024		14.7490		14.3983		14.0012		13.6522		13.4866		13.3841		13.2379		13.0644		12.9047		12.8443		12.8290		12.8356		12.8473		12.8498
November 15, 2024		14.8699		14.5688		14.1635		13.7751		13.5843		13.4650		13.2943		13.0936		12.9335		12.8662		12.8493		12.8543		12.8635		12.8659
February 15, 2025		14.9746		14.7548		14.3612		13.9270		13.7014		13.5581		13.3523		13.1147		12.9548		12.8831		12.8678		12.8717		12.8796		12.8821
May 15, 2025		15.0472		14.9451		14.6134		14.1323		13.8538		13.6715		13.4084		13.1161		12.9601		12.8927		12.8846		12.8883		12.8957		12.8982
August 15, 2025		15.0792		15.0864		14.9306		14.4541		14.0856		13.8237		13.4406		13.0623		12.9328		12.8966		12.9001		12.9039		12.9114		12.9139
November 15, 2025		15.1976		15.1976		15.1976		15.1976		15.1976		14.2857		12.9341		12.9341		12.9341		12.9341		12.9341		12.9341		12.9341		12.9341

The exact stock prices and effective dates may not be set forth in the table above, in which case:

•

if the applicable stock price is between two stock prices in the table or the applicable effective date is between two effective dates in the table, the fundamental change early settlement rate will be determined by straight line interpolation between the fundamental change early settlement rates set forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365- or 366-day year, as applicable;

•

if the applicable stock price is greater than $30.00 per share (subject to adjustment in the same manner and at the same time as the stock prices set forth in the column headings of the table above), then the fundamental change early settlement rate will be the Minimum Settlement Rate; or

•

if the applicable stock price is less than $1.50 per share (subject to adjustment in the same manner and at the same time as the stock prices set forth in the column headings of the table above, the “Minimum Stock Price”), the fundamental change early settlement rate will be determined as if the stock price equaled the Minimum Stock Price, and using straight line interpolation, as described in the first bullet of this paragraph, if the effective date is between two effective dates in the table.

The maximum number of shares of Common Stock deliverable under a Purchase Contract is 15.1976, subject to adjustment in the same manner and at the same time as the fixed settlement rates as set forth under “Description of the Purchase Contracts—Adjustments to the Fixed Settlement Rates” in the Preliminary Prospectus Supplement.


Early Mandatory Settlement at Issuer’s Election:		Issuer has the right to settle the Purchase Contracts on or after November 15, 2023, in whole but not in part, on the second business day following Issuer’s giving notice of such election if the closing price of Common Stock for 20 or more consecutive trading days ending on the second trading day immediately preceding the “notice date” (as defined under “Description of the Purchase Contracts—Early Settlement at Our Election” in the Preliminary Prospectus Supplement) exceeds 130% of the Threshold Appreciation Price in effect on each such trading day. The “early mandatory settlement rate” will be the Settlement Rate that would apply as if the notice date was the applicable early settlement date (as described in “Description of the Purchase Contracts—Delivery of Common Stock” and “Description of the Purchase Contracts—Early Settlement” in the Preliminary Prospectus Supplement).

Initial Principal Amount of Amortizing Notes:		$8.8996 per Amortizing Note $22,249,000 in aggregate (or $25,586,350 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full).

Installment Payment Dates:		Each February 15, May 15, August 15 and November 15, commencing on February 15, 2023, with a final installment payment date of November 15, 2025.

Payments on the Amortizing Notes:		The Amortizing Notes will pay holders quarterly cash installments of $0.8750 per Amortizing Note (except for the February 15, 2023 installment payment, which will be $0.8166 per Amortizing Note), which cash payment in the aggregate will be equivalent to 7.00% per annum with respect to each $50 Stated Amount of Units. Each installment will constitute a payment of interest (at a rate of 10.25% per annum) and a partial repayment of principal on the Amortizing Note, allocated as set forth in the following amortization schedule:


Scheduled Installment Payment Date	Amount of Principal		Amount of Interest
February 15, 2023	$	0.6038	$	0.2128
May 15, 2023	$	0.6624	$	0.2126
August 15, 2023	$	0.6794	$	0.1956
November 15, 2023	$	0.6968	$	0.1782
February 15, 2024	$	0.7147	$	0.1603
May 15, 2024	$	0.7330	$	0.1420
August 15, 2024	$	0.7518	$	0.1232
November 15, 2024	$	0.7710	$	0.1040
February 15, 2025	$	0.7908	$	0.0842
May 15, 2025	$	0.8110	$	0.0640
August 15, 2025	$	0.8318	$	0.0432
November 15, 2025	$	0.8531	$	0.0219


Repurchase of Amortizing Notes at the Option of the Holder:		If Issuer elects to settle the Purchase Contracts early, holders of Amortizing Notes (whether as holders of Units or separate Amortizing Notes) will have the right to require Issuer to repurchase some or all of their Amortizing Notes for cash at a repurchase price per Amortizing Note equal to the principal amount of such Amortizing Note as of the repurchase date, plus accrued and unpaid interest on such principal amount from, and including, the immediately preceding Installment Payment Date to, but not including, the repurchase date, calculated at a rate of 10.25% per annum.

Units Public Offering Price:		$50.00 per Unit $125,000,000 in the aggregate (or $143,750,000 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full).

Underwriting Discount:		$1.50 per Unit $3,750,000 in the aggregate (or $4,312,500 in the aggregate if the underwriters exercise their over-allotment option to purchase additional Units in full).

Use of Proceeds:		The net proceeds from the sale of Units in the Units Offering, after deducting the underwriting discounts and estimated offering expenses, will be approximately $120.3 million (or $138.5 million if the underwriters exercise their over-allotment option to purchase additional Units in full). Issuer intends to use the net proceeds for general corporate purposes. See “Use of Proceeds” in the Preliminary Prospectus Supplement.

Joint Book-Running Managers:		BofA Securities, Inc. Barclays Capital Inc.

Listing:		Issuer has applied to list the Units on the NYSE under the symbol “BKDT.” However, Issuer can give no assurance that the Units will be so listed. If the Units are approved for listing, Issuer expects trading on the NYSE to begin within 30 calendar days after the Units are first issued.


CUSIP for the Units:		112463 302

ISIN for the Units:		US1124633025

CUSIP for the Purchase Contracts:		112463 401

ISIN for the Purchase Contracts:		US1124634015

CUSIP for the Amortizing Notes:		112463 AD6

ISIN for the Amortizing Notes:		US112463AD65

Issuer has filed a registration statement (including a prospectus and the Preliminary Prospectus Supplement) with the Securities and Exchange Commission (the “SEC”) for the Units Offering. Before you invest, you should read the prospectus in that registration statement, the Preliminary Prospectus Supplement and other documents Issuer has filed with the SEC for more complete information about Issuer and the Units Offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting (i) BofA Securities, Inc.; Attn: Prospectus Department, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, or by telephone at (800) 294-1322, or by emailing dg.prospectus_requests@bofa.com or (ii) Barclays Capital Inc.; c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (888) 603-5847, or by emailing Barclaysprospectus@broadridge.com.

This communication should be read in conjunction with the Preliminary Prospectus Supplement and the accompanying prospectus. The information in this communication supersedes the information in the Preliminary Prospectus Supplement and the accompanying prospectus to the extent inconsistent with the information in the Preliminary Prospectus Supplement and the accompanying prospectus.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.